Wir haben festgestellt, dass Sie unsere Website von China aus besuchen.
Für Ihr Land (China) gibt es eine eigene Version der Website.

Zu China wechseln
Customer-service

Ist Ihr Interesse geweckt? Nehmen Sie Kontakt mit uns auf

Wir helfen Ihnen gerne und werden Ihre Anfrage so schnell wie möglich beantworten. 
Question

Haben Sie eine dringende Frage? Unsere Service-Hotline ist bereit

Unser Team weltweit sowie unsere Experten vor Ort stehen Ihnen zur Verfügung.

Service-Hotlines
Leave product feedback
Ressources

Suchen Sie ein Dokument? Werden Sie in unserem Resource Center fündig

Zugang zu allen Dokumenten, Videos, Artikeln, E-Learning-Modulen und weiteren Ressourcen zu all unseren Produkten.
Hamilton Medical-Logo Hamilton Logo

Ventilation for the smallest. Neonatal ventilator for the NICU and beyond

Neonatal ventilation. Available on all our ventilators

All Hamilton Medical ventilators – from high-end to transport devices – offer the option of noninvasive and invasive ventilation, with conventional and advanced ventilation modes for even the smallest patients.

Discover the most appropriate neonatal ventilator for your needs
Neonatal patient on a ventilator intubated and with a flow sensor Neonatal patient on a ventilator intubated and with a flow sensor

Precision is vital. Proximal flow measurements

The proximal flow sensor and expiratory valve enable the precise measurement of pressure and flow directly at the airway opening, ensuring the required sensitivity and a quick response time.

Neonatal patient with HFNC and mother

Careful, not too much! Tidal volumes as low as 2 ml

With the neonatal option, our devices provide tidal volumes as low as 2 ml for effective, safe, and lung-protective ventilation for neonates (Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub31​).

Designed for neonates. Demand-flow nCPAP modes

The nCPAP modes are designed in such a way that you only need to set the desired CPAP/PEEP. The flow is subsequently adjusted automatically based on the patient need (demand flow) and variation in leakage, which prevents unintended peak pressures or loss of CPAP/PEEP, and guarantees leak compensation.

Discover the ventilation modes for neonates
Trisha Degoyer Bimari Treuren Kathy Lira

Kundenstimmen

Die Möglichkeit, nCPAP beim HAMILTON‑T1 verwenden zu können, ist für uns ein grosser Vorteil. Bei bestimmten Babys ist es nicht mehr nötig, sie nur für den Transport zu intubieren.

Trisha Degoyer

Beatmungspflegerin für Neugeborene bei Life Flight
Intermountain Life Flight, Salt Lake City (UT), USA

Kundenstimmen

Der HAMILTON‑G5 bietet uns viele verschiedene Optionen und Funktionen, die auf der Neugeborenenintensivstation alle dringend benötigt werden.

Bimari Treuren

Klinikaufsicht Atemtherapie
Florida Hospital for Children, Orlando (FL), USA

Kundenstimmen

Der HAMILTON-C3 ist ein vollständig transportierbares Beatmungsgerät. Unsere empfindlichen Patienten können auf dem Weg in den OP die ganze Zeit am selben Beatmungsgerät angeschlossen bleiben.

Kathy Lira

Ausbildungskoordinatorin Neonaten/Pädiatrie
University Medical Center, Lubbock (TX), USA

Consumables and accessories specifically designed for neonates

Nuflow nasal cannula set

Nuflow nasal cannula set

Neonatal flow sensor

Neonatal flow sensor

nCPAP starter kit

nCPAP starter kit

Infant single limb breathing set for the HAMILTON-H900 humidifier

Infant breathing set for the HAMILTON-H900 humidifier

Devices

HAMILTON-C6 ventilator for neonates

HAMILTON-C6

HAMILTON-C3 ventilator for neonates

HAMILTON-C3

HAMILTON-C1 ventilator for neonates

HAMILTON-C1

HAMILTON-T1 ventilator for neonates

HAMILTON-T1

HAMILTON-MR1 ventilator for neonates

HAMILTON-MR1

Get in touch! We find the right solution for you

Book a free personal demonstration with one of our specialists to explore the benefits of our NICU ventilators further. They can guide you through the features, functionalities, and suitability of our devices based on your specific needs.

Alternatively, you can schedule a callback, and our team will reach out to provide you with the necessary information and assistance.

For more information

Dokument
Neonatal ventilation brochure SW3.0.x
Englisch | 1,57 MB | ELO20180806N.01
Dokument
HAMILTON-T1 brochure Software version 3.0.x
Englisch | 4,47 MB | 689331.07
Dokument
HAMILTON-C1 neo Brochure Software version 3.0.x
Englisch | 1,58 MB | 689574.01
Dokument
Nuflow nasal cannula for oxygen therapy in pediatrics brochure USA Version
Englisch | 0,61 MB | ELO20200103.00

Fußnoten

Referenzen

  1. 1. Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub3

Volume-targeted versus pressure-limited ventilation in the neonate.

Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub3



BACKGROUND

Damage caused by lung overdistension (volutrauma) has been implicated in the development bronchopulmonary dysplasia (BPD). Modern neonatal ventilation modes can target a set tidal volume as an alternative to traditional pressure-limited ventilation using a fixed inflation pressure. Volume targeting aims to produce a more stable tidal volume in order to reduce lung damage and stabilise pCO(2)

OBJECTIVES

To determine whether volume-targeted ventilation (VTV) compared with pressure-limited ventilation (PLV) leads to reduced rates of death and BPD in newborn infants. Secondary objectives were to determine whether use of VTV affected outcomes including air leak, cranial ultrasound findings and neurodevelopment.

SEARCH STRATEGY

The search strategy comprised searches of the Cochrane Central Register of Controlled Trials, MEDLINE PubMed 1966 to January 2010, and hand searches of reference lists of relevant articles and conference proceedings.

SELECTION CRITERIA

All randomised and quasi-randomised trials comparing the use of volume-targeted versus pressure-limited ventilation in infants of less than 28 days corrected age.

DATA COLLECTION AND ANALYSIS

Two review authors assessed the methodological quality of eligible trials and extracted data independently. When appropriate, meta-analysis was conducted to provide a pooled estimate of effect. For categorical data the relative risk (RR) and risk difference (RD) were calculated with 95% confidence intervals. Number needed to treat was calculated when RD was statistically significant. Continuous data were analysed using weighted mean difference.

MAIN RESULTS

Twelve randomised trials met our inclusion criteria; nine parallel trials (629 infants) and three crossover trials (64 infants).The use of VTV modes resulted in a reduction in the combined outcome of death or bronchopulmonary dysplasia [typical RR 0.73 (95% CI 0.57 to 0.93), NNT8 (95% CI 5 to 33)]. VTV modes also resulted in reductions in pneumothorax [typical RR 0.46 (95% CI 0.25 to 0.84), NNT 17 (95% CI 10 to 100)], days of ventilation [MD -2.36 (95% CI -3.9 to -0.8)], hypocarbia [typical RR 0.56 (95%CI 0.33 to 0.96), NNT 4 (95% CI 2 to 25)] and the combined outcome of periventricular leukomalacia or grade 3-4 intraventricular haemorrhage [typical RR 0.48 (95% CI 0.28 to 0.84), NNT 11 (95% CI 7 to 50)].

AUTHORS' CONCLUSIONS

Infants ventilated using VTV modes had reduced death and chronic lung disease compared with infants ventilated using PLV modes. Further studies are needed to identify whether VTV modes improve neurodevelopmental outcomes and to compare and refine VTV strategies.